Related Experiment Video
Updated: May 5, 2026
13:04
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
12.1K
Quantifying preferences for urea cycle disorder treatments using a discrete choice experiment
Josiah Edelblut1, Jeffrey R Skaar1, John Hilton2
1Trinity Life Sciences, Waltham, MA, USA.
Journal of Medical Economics
|March 16, 2024
Summary
Masking the taste and odor of nitrogen-binding medications is crucial for improving patient adherence in urea cycle disorders (UCDs). Optimizing these attributes can enhance treatment outcomes for UCD patients.
Area of Science:
- Medical Science
- Pharmacology
- Patient Adherence Studies
Background:
- Urea cycle disorders (UCDs) lead to ammonia accumulation and central nervous system toxicity.
- Nitrogen-binding medications are effective but face adherence challenges due to certain attributes.
Purpose of the Study:
- To quantify administration-related attributes influencing prescription selection and patient adherence for UCD treatments.
- To identify key factors impacting healthcare provider choices and patient compliance.
Main Methods:
- A web-based quantitative survey with discrete choice experiment (DCE) methodology was used.
- Healthcare providers evaluated hypothetical treatment profiles based on attributes like taste, route, and preparation.
- Relative importance (RI) scores and preference weights were assessed using a Likert scale.
Main Results:
- Taste/odor (24%) and route of administration (17%) were key for prescription selection; taste/odor (28%) and preparation (21%) were key for adherence.
- Masking taste/odor significantly increased preference for both prescription selection and adherence.
- Respondents expressed dissatisfaction with current treatment attributes.
Conclusions:
- Taste/odor is the most significant attribute influencing both prescribing decisions and patient adherence in UCDs.
- Masking the taste and odor of nitrogen-binding medications is recommended to improve adherence and patient outcomes.
- Optimizing medication attributes can positively impact the management of urea cycle disorders.
Related Concept Videos
01:23Urea Cycle
44.1K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
44.1K
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
419
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
419
01:28Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
01:23Dosage Regimen Designs: Nomograms and Tabulations
353
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
353